GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 53 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $319,422 | +25.8% | 185,711 | +42.6% | 0.00% | – |
Q2 2023 | $253,935 | -66.9% | 130,223 | -52.8% | 0.00% | – |
Q1 2023 | $766,627 | +78.0% | 275,765 | +120.9% | 0.00% | – |
Q4 2022 | $430,670 | +35.0% | 124,832 | +0.6% | 0.00% | – |
Q3 2022 | $319,000 | -15.6% | 124,086 | -20.5% | 0.00% | – |
Q2 2022 | $378,000 | -68.3% | 156,015 | -46.2% | 0.00% | – |
Q1 2022 | $1,194,000 | -79.0% | 289,897 | -34.4% | 0.00% | -100.0% |
Q4 2021 | $5,681,000 | +736.7% | 441,761 | +603.2% | 0.00% | – |
Q3 2021 | $679,000 | +121.2% | 62,825 | +86.6% | 0.00% | – |
Q2 2021 | $307,000 | -65.0% | 33,665 | -63.8% | 0.00% | – |
Q1 2021 | $877,000 | +492.6% | 93,050 | +147.2% | 0.00% | – |
Q4 2020 | $148,000 | -25.3% | 37,635 | -49.8% | 0.00% | – |
Q3 2020 | $198,000 | -22.0% | 74,942 | +95.6% | 0.00% | – |
Q2 2020 | $254,000 | +84.1% | 38,307 | +61.6% | 0.00% | – |
Q1 2020 | $138,000 | -45.2% | 23,711 | -15.7% | 0.00% | – |
Q4 2019 | $252,000 | +113.6% | 28,122 | +105.0% | 0.00% | – |
Q3 2019 | $118,000 | -6.3% | 13,716 | +21.1% | 0.00% | – |
Q2 2019 | $126,000 | -97.0% | 11,324 | -96.2% | 0.00% | -100.0% |
Q3 2018 | $4,211,000 | – | 295,711 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |